Abstract:Background: Fabry disease is an X-linked disorder caused by a deficiency of the lysosomal enzyme α-galactosidase A, resulting in accumulation of glycosphingolipids in multiple organs, primarily heart, kidneys, skin, CNS, and lungs. Materials and method: A systematic literature search was performed using the PubMed database, leading to a total number of 154 hits. Due to language restriction, this number was reduced to 135; 53 papers did not concern Fabry disease, 19 were either animal studies or gene therapy studies, and 36 papers did not have lung involvement in Fabry disease as a topic. The remaining 27 articles were relevant for this review. Results: The current literature concerning lung manifestations describes various respiratory symptoms such as dyspnoea or shortness of breath, wheezing, and dry cough. These symptoms are often related to cardiac involvement in Fabry disease as respiratory examinations are seldom performed. Pulmonary function tests primarily show obstructive airway limitation, but a few articles also report of patients with restrictive limitation and a mixture of both. No significant association has been found between smoking and the development of symptoms or spirometry abnormalities in patients with Fabry disease. Electron microscopy of lung biopsy and induced sputum show lamellar inclusion bodies (Zebra bodies) in the cytoplasm of cells in the airway wall. X-ray and CT scan have shown patchy ground-glass pulmonary infiltrations, fibrosis, and air trapping. Fibrosis diagnosed by high-resolution CT has not been significantly correlated with lung spirometry. Conclusion: Consistent findings have not been shown in the current literature. Pulmonary function tests and registration of symptoms showed various results; however, there is a trend towards obstructive airway limitation in patients with Fabry disease. Further studies are needed to evaluate pathogenesis, progression, and the effects of treatment.

[Respiratory manifestations in von Recklinghausen's disease]

Orthopaedic manifestations of neurofibromatosis type 1: A case report

Neurofibromatosis type 1 and pneumoconiosis: A case report on a coincidence

Neurocognitive and Neuropsychiatric Implications of Fibrosing Interstitial Lung Diseases

Clinical manifestations of neurofibromatosis type 1 – a diagnostic and management challenge

Spontaneous primary pneumothorax as a complication of neurofibromatosis type 1

[The Pulmonary Dysfunction Patterns in Scoliosis Associated with Neurofibromatosis Type I].

Solitary Isolated Oropharyngeal Neurofibroma Presenting With Dysphagia in the Setting of Von Recklinghausen's Disease

Pictorial Review and Retrospective Study of Their Frequency in a Cohort of Patients

Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey

[NF2: ocular, neural and genetic manifestations]

Respiratory Complications in Children with Neurological Diseases

Neurofibromatosis type 1 with huge intrathoracic meningoceles misdiagnosed as pleural effusion: A case report and literature review

Endocrine Conditions in Neurofibromatosis 1

Respiratory Function in Friedreich's Ataxia

Place of surgery in the treatment of plexiform nevroma of the face plexiform nevroma of the face: about 09 cases of von recklinghausen disease

Satisfaction from surgical treatment and its influence on the wellbeing of patients with Recklinghausen disease - preliminary report

Vascular Abnormalities and Neurofibromatosis Type 1: A Paediatric Case Series

Fabry disease, respiratory symptoms, and airway limitation - a systematic review

Chronische Rhinosinusitis bei Menschen mit zystischer Fibrose – eine aktuelle Übersicht aus der Perspektive der Hals‐, Nasen‐, Ohrenheilkunde

Retinal Reactive Astrocytic Tumor and Astrocytic hamartomas in patient with Neurofibromatosis type 1: Case Report and Literature review